CareLit · DOI-Nachweis · Zeitschrift für Gastroenterologie
Thyroid dysfunction induced by peginterferon alfa-2b (Peg-2b)/Ribavirin (Rbv) is associated with higher SVR rates in patients with HCV Genotype 1 (G1) infection due to improved early virologic response at week 4 and week 12
DOI 10.1055/s-0033-1352956
Bibliografische Angaben
Nachweis in CareLit
Autor:innenS Mauss, D Hüppe, E Zehnter, MP Manns, G Teuber, T Dahhan, U Meyer, T Witthöft, B Möller, N Dikopoulos, J Brack, B Dreher, D Hartmann, M Bilzer
ZeitschriftZeitschrift für Gastroenterologie
Ausgabe08/2013
Jahrgang / SeitenNicht angegeben
Kernaussage aus der Literatur
Abstract-Vorschau
Aims: Recently, we have shown that patients (pts) who developed thyroid dysfunction during treatment of HCV G1 infection with peginterferon alfa-2b and ribavirin yielded higher SVR rates. In order to better understand this beneficial effect we investigated the impact of thyroid dysfunction on early virologic response. Methods: Data from pts treated for G1 (N = 1923) infection with Peg2b 1.5 µg/kg/wk + weight-based R…
Zitieren
Zitierempfehlung
S Mauss, D Hüppe, E Zehnter, MP Manns, G Teuber, T Dahhan, U Meyer, T Witthöft, B Möller, N Dikopoulos, J Brack, B Dreher, D Hartmann, M Bilzer (2013) Thyroid dysfunction induced by peginterferon alfa-2b (Peg-2b)/Ribavirin (Rbv) is associated with higher SVR rates in patients with HCV Genotype 1 (G1) infection due to improved early virologic response at week 4 and week 12. Zeitschrift für Gastroenterologie (08). https://doi.org/10.1055/s-0033-1352956
Mit CareLit weiterarbeiten